Disease: Plasma cell leukemia
- A Case Report of Cytarabine-Induced Red Ear Syndrome
- A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples
- A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia
- A rare presentation of spontaneous splenic rupture from plasma cell leukaemia-a case report
- AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity
- ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
- Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience
- Ankrd26 is a retinoic acid-responsive plasma membrane-binding and -shaping protein critical for proper cell differentiation
- Anti-allergic effect of vitamin C through inhibiting degranulation and regulating T(H) 1/T(H) 2 cell polarization
- ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
- Bee Venom: Composition and Anticancer Properties
- Biallelic variation in the choline and ethanolamine transporter <em>FLVCR1</em> underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders
- Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
- Blood plasma metagenomic next-generation sequencing for identifying pathogens of febrile neutropenia in acute leukemia patients
- Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <em>EGFR</em>-Mutant NSCLC Informs Potential Therapeutic Targets
- Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets
- Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
- CAR-T Cell Therapy for T-Cell Malignancies
- Case of angioimmunoblastic T-cell lymphoma presenting as peripheral and bone marrow plasmacytosis: A diagnostic conundrum
- CD20 CAR T cells safely and reversibly ablate B cell follicles in a non-human primate model of HIV persistence
- Cell intrinsic mechanical regulation of plasma membrane accumulation at the cytokinetic furrow
- CircFN1 promotes acute myeloid leukemia cell proliferation and invasion but refrains apoptosis via miR-1294/ARHGEF10L axis
- Coincidence of plasma cell leukemia and COVID-19: a diagnostic pitfall
- Combination p53 activation and BCL-x(L)/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
- Comparable Efficacy of Oral Bendamustine versus Intravenous Administration in Treating Hematologic Malignancies
- Complete Rescue of HTLV-1<sub>p12KO</sub> Infectivity by Depletion of Monocytes Together with NK and CD8<sup>+</sup> T Cells
- Correction: Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line
- Cross-sectional network analysis of plasma proteins/metabolites correlated with pathogenesis and therapeutic response in acute promyelocytic leukemia
- Cryocrystalglobulinemia Leading to Multi-Organ Failure in Chronic Lymphocytic Leukemia Achieving Complete Renal Recovery
- Daratumumab-based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
- Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity
- Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry
- Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
- Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
- Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients - A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals
- Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals
- Dual targeting of glutamine and serine metabolism in acute myeloid leukemia
- Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
- Early Detection and Diagnostic Approach Through Automated Hematological Analysis for Plasma Cell Leukemia
- Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma
- Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia
- Elucidation of molecular basis of osteolytic bone lesions in advanced multiple myeloma
- EXPRESS: A new therapeutic perspective: erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes
- Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients
- FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis
- FLVCR1a Controls Cellular Cholesterol Levels through the Regulation of Heme Biosynthesis and Tricarboxylic Acid Cycle Flux in Endothelial Cells
- From Multiple Myeloma to Acute Myeloid Leukemia: A Case Report of a 61-year-old Woman after 8 Years of Chemotherapy and Immunotherapy
- Genomic technologies for detecting structural variations in hematologic malignancies
- Hairy cell leukemia with plasmacytoid morphology
- Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice
- Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study
- Identifying a core protein signature of small extracellular vesicles derived from B-cell precursor acute lymphoblastic leukaemia
- IL-18-secreting multi-antigen targeting CAR T-cells eliminate antigen-low myeloma in an immunocompetent mouse model
- Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies
- Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry
- Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche
- Interpreting single-cell messages in normal and aberrant hematopoiesis with the Cell Marker Accordion
- LATS1 Promotes B-ALL Tumorigenesis by Regulating YAP1 Phosphorylation and Subcellular Localization
- Liquid Chromatography-Tandem Mass Spectrometry-Based Therapeutic Monitoring of Plasma Atovaquone Concentrations in Pediatric Patients
- Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases - A mixed method study
- Mining phase separation-related diagnostic biomarkers for endometriosis through WGCNA and multiple machine learning techniques: a retrospective and nomogram study
- Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administration
- Multiple cancer cell types release LIF and Gal3 to hijack neural signals
- Ozone alleviates MSU-induced acute gout pain via upregulating AMPK/GAS6/MerTK/SOCS3 signaling pathway
- Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
- Pharmacological profiling of a berbamine derivative for lymphoma treatment
- PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine
- Plasma cell leukemia with soft tissue involvement; reporting a rare case
- Plasma Cell Leukemia-Clinicopathological Profile from a Tertiary Care Center in Western India
- Plasma microbial cell-free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia
- Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia
- Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation-A 10-Year Single-Center Experience
- Primary plasma cell leukaemia in a 22-year-old woman: A case report
- Primary plasma cell leukaemia presenting as unilateral proptosis
- Primary plasma cell leukemia presented with atypical flower-like morphology
- Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Quantification of Measurable Residual Disease Detection by Next Generation Sequencing-based Clonality Testing in B-cell and Plasma Cell Neoplasms
- Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
- Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States
- Real-world analysis of teclistamab in 123 RRMM patients from Germany
- Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model
- Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells
- Report on hematopoietic cell transplantations performed in 2018/2019 focusing on the trends of selection of stem cell sources in the Asia-Pacific region: APBMT Activity Survey
- RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies
- Secondary plasma cell leukaemia (PCL) with plasmablastic morphology
- Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry
- Simultaneous Purification of Human Interferon Alpha-2b and Serum Albumin Using Bioprivileged Fluorinated Ionic Liquid-Based Aqueous Biphasic Systems
- SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
- Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma
- Structural characterization and origin of surface vesicles in monocytes: another membranous pathway from cytoplasm to cell surface
- Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting
- System analysis of surface CD markers during the process of granulocytic differentiation
- The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)
- Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia
- Thrombopoietin-independent generation of platelet-like particles from megakaryoblastic cells
- Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
- TXNDC12 inhibits lipid peroxidation and ferroptosis
- Uncommon Haematological Transformation: Chronic Myeloid Leukaemia Transitioning Into Plasma Cell Leukaemia in a Single Patient
- Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts-implications for acute myeloid leukaemia